Avenue Therapeutics Inc.
13F holders, Q1 2024 (March 31)14holders
1famous investor
$0.15avg. 13F price*
At the end of Q1 2024, 14 institutions reported holding Avenue Therapeutics Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($99K), Two Sigma Securities, LLC ($26K) and Susquehanna International Group, LLP ($11K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Avenue Therapeutics Inc.
- CUSIP
- 05360L304
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $114K |
| Exits | 5 | $17K |
Ownership 14 holders
| Sabby Management, LLC | 0.71% | New | 670,926 | $99K |
| Two Sigma Securities, LLC | 0.00% | Add +547.4% | 178,025 | $26K |
| Susquehanna International Group, LLP | 0.00% | New | 71,947 | $11K |
| Geode Capital Management, LLC | 0.00% | No change | 52,160 | $8K |
| Vanguard Group Inc. | 0.00% | No change | 46,293 | $7K |
| HRT Financial LP | 0.00% | Add +82.8% | 46,227 | $6K |
| State Street Corp. | 0.00% | No change | 30,593 | $5K |
| Jane Street Group, LLC | 0.00% | New | 29,937 | $4K |
| Millennium Management | 0.00% | Reduce -63.3% | 10,501 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +30.2% | 8,872 | $1K |
| Wells Fargo & Company | 0.00% | Add +3.8% | 4,801 | $709 |
| Emfo, LLC | 0.00% | No change | 533 | $79 |
| JPMorgan Chase & Co. | 0.00% | New | 5 | $1 |
| Royal Bank of Canada | 0.00% | Add +7.8% | 554 | $0 |
"% of holder's portfolio" is AVENUE THERAPEUTICS INC's weight in each manager's 13F, not the share of Avenue Therapeutics Inc. the manager owns.